ArticleCell reports. Medicine2025

Development of a cyst-targeted therapy for polycystic kidney disease using an antagonistic dimeric IgA monoclonal antibody against cMET.

Margaret F Schimmel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.